Imperagen raises $6.7M Seed (United Kingdom, May 2026)
Reach the investors backing rounds like this
Backed by PXN Ventures, IQ Capital +1 more · verified emails and LinkedIn on Datapile
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering - TechCrunch
Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering TechCrunch
14,302 investors back startups in United Kingdom
You just read who funded Imperagen. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.